Ray Therapeutics, a developer of optogenetic gene therapies for patients with blinding diseases, has raised $6 million in seed financing. The lead backer was 4Bio Capital.
Source: Press Release
Ray Therapeutics snags $6m seed
Ray Therapeutics, a developer of optogenetic gene therapies for patients with blinding diseases, has raised $6 million in seed financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: